e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Primary care and nursing management of patients with chronic pulmonary disease in multiple settings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension
E. Vandevelde, V. De Broyer, E. Smeyers, M. Stas, M. Delcroix (Leuven, Belgium)
Source:
Annual Congress 2004 - Primary care and nursing management of patients with chronic pulmonary disease in multiple settings
Session:
Primary care and nursing management of patients with chronic pulmonary disease in multiple settings
Session type:
Thematic Poster Session
Number:
3875
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Vandevelde, V. De Broyer, E. Smeyers, M. Stas, M. Delcroix (Leuven, Belgium). Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension. Eur Respir J 2004; 24: Suppl. 48, 3875
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Infections of indwelling central venous catheters among patients treated with intravenous epoprostenol for pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Surveillance of tunnelled central venous catheter infections in patients with pulmonary arterial hypertension (PAH) treated with
i.v.
iloprost
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Complications of a permanently implanted port system for continuous epoprostenol treatment in pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002
Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
Source: International Congress 2017 – NICU/ PICU: evaluating short- and long-term ventilatory management
Year: 2017
Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Successful artocoronary bypass grafting in a patient with severe idiopathic pulmonary arterial hypertension: use of intravenous treprostinil
Source: Eur Respir J 2006; 28: Suppl. 50, 384s
Year: 2006
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 595-600
Year: 2004
Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
Source: Eur Respir J 2006; 28: 1195-1203
Year: 2006
Low dose intravenous iloprost therapy in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006
Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Antecubital venous access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Initial combination therapy with epoprostenol and bosentan in severe pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Intravenous line complications during continuous iloprost therapy using directly inserted subclavian catheters
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2003; 22: Suppl. 45, 461s
Year: 2003
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019
Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2014; 23: 393-395
Year: 2014
Central venous catheter infections in out-patients with pulmonary hypertension treated with continuous iloprost
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (5) 1802095; 10.1183/13993003.02095-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept